Contestants After PAMO opening ceremony

Team Botswana

Team Kenya

Dr H. Were patron MANU with outgoing MANU student leaders

Dr H. Were Patron MANU with newly elected student leaders

Ms Regina Muriuki, Education Development Officer at ACCA talking to students.

26th Pan African Mathematics Olympiad PAMO 2018 Date :23rd to 30th June 2018

Workshop: 27-31 August 2018

Pre-workshop school: 21-24 August 2018

Dr Njagi will be lecturing a 5 day course in Biostatistical Models for Joint Longitudinal and Survival Data in Medical Research.

- 1 of 9
- ››

BY YEAR | BY AUTHOR | BY TITLE | BY COLLEGE/FACULTY/DEPARTMENT

Dr. Stephen Kibet Moindi Publications | ||||

1 | 9999 | Stephen Moindi Kibet, G.P. Pokhariyal And B.M. Nzimbi, W_2-Recurrent LP-Sasakian Manifold, Universal Journal Of Mathematics And Mathematical Sciences(UMMS) Accepted In May 2012. Paper Under Review.Click to View Abstract Aminoglutethimide (AG) 500 mg was administered orally to four normal volunteers and eight patients undergoing treatment for metastatic breast cancer. In each subject the acetylator phenotype was established from the monoacetyldapsone (MADDS)/dapsone (DDS) ratio. Acetylaminoglutethimide (acetylAG) rapidly appeared in the plasma and its disposition paralleled that of AG. A close relationship (P less than 0.01) was observed between the acetyl AG/AG and MADDS/DDS ratio suggesting that AG may undergo polymorphic acetylation like DDS. AG half-life was 19.5 +/- 7.7 h in seven fast acetylators of DDS and 12.6 +/- 2.3 h in five slow acetylators and its apparent metabolic clearance was significantly (P less than 0.01) related to the acetylAG/AG ratio. Over 48 h the fast acetylators excreted 7.7 +/- 4.4% of the administered AG dose in the urine as unchanged AG as compared to 12.4 +/- 2.8% in slow acetylators. A much smaller fraction of the dose was excreted as acetylAG: 3.6 +/- 1.5% by fast and 1.9 +/- 1.0% by slow acetylators respectively. After 7 days treatment with AG at an accepted clinical dose regimen to the eight patients there were significant reductions in the half-lives of AG (P less than 0.01) and acetylAG (P less than 0.01) and a trend (0.1 greater than P greater than 0.05) towards reduction of the acetylAG/AG ratio which became significant (P less than 0.05) if the one patient on a known enzyme inducer was omitted. The mean apparent volume of distribution was not significantly (P greater than 0.1) altered but the mean apparent systemic clearance of AG was increased (P less than 0.05). These changes are attributed to auto-induction of oxidative enzymes involved in AG metabolism. | ||

2 | 9999 | Moindi, S.K., Pokhariyal, G.P. And Nzimbi, B.M., W_4-Curvature Tensor On A A-Einstein Sasakian Manifold, Global Journal Of Theoretical And Applied Mathematical Sciences(GJTAMS), Accepted Feb 2012, To Appear.Click to View Abstract Aminoglutethimide (AG) 500 mg was administered orally to four normal volunteers and eight patients undergoing treatment for metastatic breast cancer. In each subject the acetylator phenotype was established from the monoacetyldapsone (MADDS)/dapsone (DDS) ratio. Acetylaminoglutethimide (acetylAG) rapidly appeared in the plasma and its disposition paralleled that of AG. A close relationship (P less than 0.01) was observed between the acetyl AG/AG and MADDS/DDS ratio suggesting that AG may undergo polymorphic acetylation like DDS. AG half-life was 19.5 +/- 7.7 h in seven fast acetylators of DDS and 12.6 +/- 2.3 h in five slow acetylators and its apparent metabolic clearance was significantly (P less than 0.01) related to the acetylAG/AG ratio. Over 48 h the fast acetylators excreted 7.7 +/- 4.4% of the administered AG dose in the urine as unchanged AG as compared to 12.4 +/- 2.8% in slow acetylators. A much smaller fraction of the dose was excreted as acetylAG: 3.6 +/- 1.5% by fast and 1.9 +/- 1.0% by slow acetylators respectively. After 7 days treatment with AG at an accepted clinical dose regimen to the eight patients there were significant reductions in the half-lives of AG (P less than 0.01) and acetylAG (P less than 0.01) and a trend (0.1 greater than P greater than 0.05) towards reduction of the acetylAG/AG ratio which became significant (P less than 0.05) if the one patient on a known enzyme inducer was omitted. The mean apparent volume of distribution was not significantly (P greater than 0.1) altered but the mean apparent systemic clearance of AG was increased (P less than 0.05). These changes are attributed to auto-induction of oxidative enzymes involved in AG metabolism. | ||

3 | 9999 | B.M. Nzimbi, G.P. Pokhariyal And S.K. Moindi, A Note On Metric Equivalence Of Operators, Far East Math Jourmal (FMJS), Accepted March 2012, To Appear.Click to View Abstract Aminoglutethimide (AG) 500 mg was administered orally to four normal volunteers and eight patients undergoing treatment for metastatic breast cancer. In each subject the acetylator phenotype was established from the monoacetyldapsone (MADDS)/dapsone (DDS) ratio. Acetylaminoglutethimide (acetylAG) rapidly appeared in the plasma and its disposition paralleled that of AG. A close relationship (P less than 0.01) was observed between the acetyl AG/AG and MADDS/DDS ratio suggesting that AG may undergo polymorphic acetylation like DDS. AG half-life was 19.5 +/- 7.7 h in seven fast acetylators of DDS and 12.6 +/- 2.3 h in five slow acetylators and its apparent metabolic clearance was significantly (P less than 0.01) related to the acetylAG/AG ratio. Over 48 h the fast acetylators excreted 7.7 +/- 4.4% of the administered AG dose in the urine as unchanged AG as compared to 12.4 +/- 2.8% in slow acetylators. A much smaller fraction of the dose was excreted as acetylAG: 3.6 +/- 1.5% by fast and 1.9 +/- 1.0% by slow acetylators respectively. After 7 days treatment with AG at an accepted clinical dose regimen to the eight patients there were significant reductions in the half-lives of AG (P less than 0.01) and acetylAG (P less than 0.01) and a trend (0.1 greater than P greater than 0.05) towards reduction of the acetylAG/AG ratio which became significant (P less than 0.05) if the one patient on a known enzyme inducer was omitted. The mean apparent volume of distribution was not significantly (P greater than 0.1) altered but the mean apparent systemic clearance of AG was increased (P less than 0.05). These changes are attributed to auto-induction of oxidative enzymes involved in AG metabolism. | ||

4 | 9999 | B.M. Nzimbi, G.P. Pokhariyal And S.K. Moindi, A Note On A-self-adjoint And A-skew-adjoint Operators And Their Extensions, Pioneer Journal Of Mathematics And Mathematical Sciences, Accepted January, 2012, To AppearClick to View Abstract | ||

5 | 9999 | Justus K. Mile, Bernard M. Nzimbi And S.K. Moindi, On The Characterization Of Class R_1 Of Non-normal Operators In A Hilbert Space, Pioneer Journal Of Mathematics And Mathematical Sciences(PMMS), Accepted March 2012, To Appear.Click to View Abstract | ||

6 | 2012 | W_4-Curvature Tensor On A A-Einstein Sasakian Manifold, Global Journal Of Theoretical And Applied Mathematical Sciences(GJTAMS), Accepted Feb 2012, To Appear.Click to View Abstract
| ||

7 | 2010 | Stephen Moindi Kibet, G.P. Pokhariyal And B.M. Nzimbi, Study Of W_4 Curvature Tensor On Sasakian Manifold, Kenya J. Sciences(KJS), Vol. 14, No.1 2010, 1-8Click to View Abstract |

School of Mathematics, CBPS College.

P. O. Box 30197 - 00100

Tel: 254-02-4445751.

Mobile no :0780-834766.

Email: maths@uonbi.ac.ke.

twitter:@uon_maths

UoN Website | UoN Repository | ICTC Website

Copyright © 2018. ICT WebTeam, University of Nairobi